Dr. Maura Gillison, MD
Claim this profileM D Anderson Cancer Center
Studies Squamous Cell Carcinoma
Studies Skin Cancer
7 reported clinical trials
18 drugs studied
Area of expertise
1Squamous Cell Carcinoma
p16 positive
Stage IV
PD-L1 positive
2Skin Cancer
p16 positive
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Maura Gillison, MD is currently running
SGN-PDL1V
for Cancer
This trial is testing a new drug, SGN-PDL1V, alone and with pembrolizumab, in patients with advanced solid tumors. The goal is to see if these treatments are safe and effective. SGN-PDL1V targets cancer cells directly, while pembrolizumab helps the immune system fight the cancer.
Recruiting1 award Phase 1
Tipifarnib + Alpelisib
for Head and Neck Cancer
This trial tests a combination of two drugs, tipifarnib and alpelisib, in patients with advanced head and neck cancer that have specific genetic changes. The drugs aim to stop cancer growth by blocking essential enzymes. Tipifarnib is a farnesyl transferase inhibitor that has shown clinical activity in head and neck squamous cell carcinoma, particularly in tumors with HRAS mutations.
Recruiting1 award Phase 1 & 2
More about Maura Gillison, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Maura Gillison, MD has experience with
- Carboplatin
- Nivolumab
- Atezolizumab
- Cisplatin
- Standard Of Care
- Tiragolumab
Breakdown of trials Maura Gillison, MD has run
Squamous Cell Carcinoma
Skin Cancer
Oral Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maura Gillison, MD specialize in?
Maura Gillison, MD focuses on Squamous Cell Carcinoma and Skin Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved p16 positive patients, or patients who are Stage IV.
Is Maura Gillison, MD currently recruiting for clinical trials?
Yes, Maura Gillison, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Maura Gillison, MD has studied deeply?
Yes, Maura Gillison, MD has studied treatments such as Carboplatin, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Maura Gillison, MD?
Apply for one of the trials that Maura Gillison, MD is conducting.
What is the office address of Maura Gillison, MD?
The office of Maura Gillison, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.